Bin Kong

Prof. Bin Kong


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2023 in International Immunopharmacology
Verified
Journal Article
Closed access
WZWeiran Zhang
Weiran Zhang
DLDaisong Li
Daisong Li
BLBing Li
Bing Li
XCXian-Ming Chu
Xian-Ming Chu
BKBin Kong
Bin Kong

11 November 2020 in Cytotechnology
Verified
Journal Article
Closed access
PDF file
LLLinWei Li
LinWei Li
JXJing Xia
Jing Xia
RCRuTing Cui
RuTing Cui
BKBin Kong
Bin Kong

3 October 2022 in Research Square
Verified
Preprint
Open access
PDF file
WZWeiran Zhang
Weiran Zhang
HSHongming Song
Hongming Song
JXJing Xia
Jing Xia
YHYuqi Huan
Yuqi Huan
XWXiaowei Wang
Xiaowei Wang
BKBin Kong
Bin Kong
Background: Chromatin regulators (CRs) are indispensable upstream regulatory factors of epigenetics and play an important role in cancer progression. Herein, we explored the relationship between CRs and breast cancer (BC) through bioinformatics to improve BC prognosis and treatment. Methods: The RNA sequencing (RNA-seq) profiles and clinical data were retrieved from the Gene Expression Omnibus (GEO) database. Univariate Cox regression analysis and the least absolute shrinkage and selection operator (LASSO) regression were used to build a prognostic model. Patients were divided into high and low-risk groups according to the risk score. Then, a nomogram was constructed based on the selected clinical features and risk score. The differences in immune cell infiltration and checkpoints were estimated for the high and low-risk groups. Results: We established and validated a prognostic model of BC patients based on 4 CRs-related genes (MORF4L1, NCOA4, TTK and JMJD4). The high-risk group presented poor prognosis. The immune-correlation analysis also showed that the high-risk group might response to immunotherapy. Conclusion: We successfully established a reliable 4 CRs-related prognostic model and provided novel insights for evaluating immune infiltration and guiding the treatment of BC patients.